Lifecore Biomedical, Inc.
LFCR
$7.24
-$0.52-6.70%
NASDAQ
| 05/25/2025 | 02/23/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.67% | 7.95% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.67% | 7.95% | |||
| Cost of Revenue | -11.25% | 17.83% | |||
| Gross Profit | 42.02% | -11.18% | |||
| SG&A Expenses | -11.03% | -5.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.42% | 9.75% | |||
| Operating Income | 226.43% | -47.46% | |||
| Income Before Tax | 92.46% | -126.36% | |||
| Income Tax Expenses | 512.50% | -118.60% | |||
| Earnings from Continuing Operations | 92.23% | -124.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 92.23% | -124.76% | |||
| EBIT | 226.43% | -47.46% | |||
| EBITDA | 2,317.97% | -144.38% | |||
| EPS Basic | 88.22% | -85.31% | |||
| Normalized Basic EPS | 55.96% | -21.90% | |||
| EPS Diluted | 88.23% | -85.55% | |||
| Normalized Diluted EPS | 55.96% | -21.90% | |||
| Average Basic Shares Outstanding | -0.03% | 7.74% | |||
| Average Diluted Shares Outstanding | -0.03% | 7.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||